Stockreport

Theranica Advances Migraine Care in 2024 Supported by New Research, an Expanded Indication, a new Chief Medical Officer, and Broader Insurance Coverage [Yahoo! Finance]

Dr. Reddy's Laboratories Ltd  (RDY) 
US:NYSE Investor Relations: drreddys.com/investors
PDF BRIDGEWATER, N.J. and NETANYA, Israel Dec. 10, 2024 /PRNewswire/ -- Theranica , a prescribed neuromodulation therapeutics company, today announced significant milestone [Read more]